Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sorbitol dehydrogenase: structure, function and ligand design.

O El-Kabbani1, C Darmanin, R P-T Chung

  • 1Department of Medicinal Chemistry, Victorian College of Pharmacy, Monash University (Parkville Campus), Parkville, Victoria 3052, Australia. ossama.el-kabbani@vcp.monash.edu.au

Current Medicinal Chemistry
|February 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The serial millisecond crystallography instrument at the Australian Synchrotron incorporating the "Lipidico" injector.

The Review of scientific instruments·2019
Same author

Bragg coherent diffraction imaging and metrics for radiation damage in protein micro-crystallography.

Journal of synchrotron radiation·2016
Same author

Radiation damage in a micron-sized protein crystal studied via reciprocal space mapping and Bragg coherent diffractive imaging.

Structural dynamics (Melville, N.Y.)·2016
Same author

Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome.

Free radical research·2014
Same author

A gel-capture assay for characterizing the sialyl-glycan selectivity of influenza viruses.

Acta virologica·2011
Same author

A new approach for structure analysis of two-dimensional membrane protein crystals using X-ray powder diffraction data.

Protein science : a publication of the Protein Society·2010
Same journal

Computational Study of ADME-TOx from Selected Phytocompounds of Solanum tuberosum and Cucumis sativus.

Current medicinal chemistry·2026
Same journal

QSAR-Based Strategies for Selective-HDAC6 Inhibitor Development: A Detailed Review.

Current medicinal chemistry·2026
Same journal

Breaking New Ground in Oncology: FDA Acceptance of Vepdegestrant NDA Marks a Milestone for PROTAC Therapies in Breast Cancer.

Current medicinal chemistry·2026
Same journal

Knockdown of circFGFR2 inhibits prostate cancer cell metastasis and proliferation by targeting miR-221-5p/ SMUG1 pathway.....

Current medicinal chemistry·2026
Same journal

LncRNA signature associated with amino acid metabolism: A novel prognostic tool for Clear Cell Renal Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

HRI Kinase Modulation by BTdCPU as a Therapeutic Strategy for Bortezomib Resistance in Prostate Cancer.

Current medicinal chemistry·2026
See all related articles

Sorbitol dehydrogenase (SDH) is crucial in glucose metabolism and implicated in diabetic complications. Understanding its structure aids in developing new diabetes treatments.

Area of Science:

  • Biochemistry
  • Enzymology
  • Structural Biology

Background:

  • Sorbitol dehydrogenase (SDH) is a key enzyme in the polyol pathway, converting sorbitol to fructose using NAD(+) as a coenzyme.
  • SDH is widely expressed in mammalian tissues and linked to the development of diabetic complications.
  • Its structural homology to alcohol dehydrogenase suggests potential for drug development targeting diabetes.

Purpose of the Study:

  • To review recent advances in the structure, function, and drug development of sorbitol dehydrogenase.
  • To highlight the role of SDH structure in developing treatments for diabetic complications.

Main Methods:

  • Review of recent structural and biochemical studies on mammalian SDH.
  • Analysis of 3-D structure data and comparison with alcohol dehydrogenase.

Related Experiment Videos

  • Exploration of structure-based drug design approaches.

    • Main Results:

    • The tertiary structure of mammalian SDH has been determined.
    • SDH shares structural homology with alcohol dehydrogenase, but with distinct zinc coordination in active sites.
    • Structural and biochemical data are being used for structure-based drug development.

    Conclusions:

    • The unique structure of SDH offers opportunities for targeted drug development.
    • Further research into SDH structure and function can lead to novel therapies for diabetes and its complications.